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Abstract 
Many important biogenic amines (dopamine, noradrenaline and serotonin) are produced 
from amino acids by enzyme-catalysed processes and play a prominent role in neuronal 
functions and therefore, they serve as pharmacological target for the treatment of neurological 
disorders, such as Alzheimer’s disease or Parkinson’s disease. 
The aim of the current study was to optimize a high-performance liquid chromatography 
method that allows selective separation of eight biogenic amines and some of their 
metabolites (levodopa, 3,4-dihydroxyphenylacetic acid, noradrenaline, 5-hydroxyindoleacetic 
acid, homovanillic acid, dopamine, serotonin and 3-methoxythyramine) using 3 internal 
standards with electrochemical detection. During the development of our method, we 
optimized the amount of ion pairing component, pH and the amount of organic phase. Several 
selective methods were tested, but the most effective one was used for validation process for 
mouse and rat brain regions, including the striatum, cortex and hippocampus. 
During validation, the limit of detection, the limit of quantification, recovery, intraday 
and interday precisions were determined for the eight analytes. The ranges of recovery were 
between 87 and 120%, the intraday and interday precision were < 10% in all cases. The limit 
of detection and quantification ranged around 2 and 10 ng/ml, respectively. 
The developed and optimized method ensures the measurement of the aforementioned 
biogenic amines from mouse and rat brain regions. 
 
Introduction 
Monitoring of the concentration of biogenic amines may have a great importance from 
several aspects [1]. The measurement of these metabolites from biological samples requires 
highly selective and sensitive methods because of their considerably low concentrations [1, 
2]. High-performance liquid chromatography (HPLC) methods have been widely applied [3] 
for this purpose. HPLC combined with electrochemical detector (ECD) is one of the best 
alternatives for the quantitative detection of monoamines and related compounds in biological 
samples because of their electroactive function groups and the exceptional sensitivity of the 
ECD. 
The aim of the current study was to optimize our latest HPLC-ECD method [3] to be 
able to determine 8 biogenic amines and some of their metabolites (levodopa (L-DOPA), 3,4-
dihydroxyphenylacetic acid (DOPAC), noradrenaline (NA), 5-hydroxyindoleacetic acid (5-
HIAA), homovanillic acid (HVA), dopamine (DA), serotonin (5-HT), 3-methoxythyramine 
(3-MT)) from different biological samples. It is essential to apply internal standard(s) (IS) for 
HPLC measurements [4, 5], therefore, based on the recommendations [4], we decided to use 3 
(3,4-dihydroxybenzylamine (DHBA), isoproterenol (IPR) and N-methyl serotonin (NM-5HT) 
instead of the previous one. After the successful extension of the method, we applied it to 
different biological samples, i.e., mice and rat brain regions and the validation process was 
carried out as well. 
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Materials and methods 
L-DOPA, 5-HT and their metabolites, DA, 3-MT, DOPAC, HVA, NA and 5-HIAA 
were measured from the striatum, cortex and hippocampus of C57Bl/6 mice and Wistar rat 
animals. We used an Agilent 1100 HPLC system (Agilent Technologies, Santa Clara, CA, 
USA) combined with a Model 105 ECD (Precision Instruments, Marseille, France) under 
isocratic conditions. The brain regions were weighed and then homogenized in an ice-cold 
solution (striatum: 60 µL/mg; cortex: 25 µL/mg and hippocampus: 18.75 µL/mg) containing 
perchloric acid (3.4 w%, Sigma Aldrich, Saint Louis, MO, USA), sodium-metabisulfite (400 
µM, Fluka, Sigma-Aldrich, Saint Louis, MO, USA), ethylenediaminetetraacetic acid 
disodium salt (Na2EDTA, 500 µM, Lach-Ner, Neratovice, Czech Republic), distilled water 
and ISs: 50 ng/ml DHBA, 200 ng/ml IPR and 100 ng/ml NM-5HT (Sigma Aldrich, Saint 
Louis, MO, USA). The homogenate was centrifuged at 12,000g for 30 min at 4°C. The 
supernatants of individual brain regions were pooled and spiked with standard solution in 
three different concentration levels. The working potential of the detector was set at +750 
mV, using a glassy carbon electrode and an Ag/AgCl reference electrode. The mobile phase 
contained sodium-dihydrogenphosphate (NaH2PO4; 75 mM, Reanal, Budapest, Hungary), Na-
octylsulphate (NaOS, 2.2 mM, Sigma Aldrich, Saint Louis, MO, USA) and Na2EDTA (50 
μM, Lach-Ner, Neratovice, Czech Republic) was supplemented with acetonitrile (ACN; 
6.25% v/v, VWR International, Radnar, PA, USA) and the pH was adjusted to 3.0 with 
phosphoric acid (H3PO4; 85% w/w, Sigma Aldrich, Saint Louis, MO, USA). The mobile 
phase was delivered at a rate of 1.5 ml/min at 40°C onto the column (Zorbax Eclipse Plus 
C18, 100 x 4.6 mm, 3.5 μm particle size; Agilent Technologies, Santa Clara, CA, USA) after 
passage through a pre-column (SecurityGuard, 4×3.0 mm i.d., Phenomenex Inc., Torrance, 
CA, USA)). 10 µL aliquots were injected by the autosampler with the cooling module set at 
4°C. 
Results 
Before validation, the optimal working potential was investigated. The detector was set 
from 400 mV to 800 mV with 50 mV increments (Fig 1a). Although 800 mV would be the 
best working potential for HVA and 3-MT, the signal-to-noise ratio also increases with the 
applied working potential, so we decided to set the detector at +750 mV. 
First we determined the effect of the change in NaOS concentration (Fig.1b) with a 
result that the increasing amount has ambivalent effect on analytes: increased retention times 
were observed in case of L-DOPA, NA, DA, 5-HT, 3-MT, IPR (IS), whereas in case of 
DOPAC, 5-HIAA and HVA the retention time decreased. The concentration of 7.5 mM was 
selective for all the compounds as well, however, the run time was more than 45 min. 
Then we checked the influence of the pH value of the mobile phase (Fig.1c). As it can 
be seen, the increasing value of pH from 3.0 to 4.0 reduced the retention time of all the 
analytes. 
These results showed that the best choice is to keep the pH at 3.0 and NaOS in the 
concentration range between 2.10 mM and 2.20 mM with 5 or 6 v/v% ACN. With the 2 new 
internal standards (DHBA and NM-5HT), the optimal mobile phase consists of 2.20 mM 
NaOS, 75 mM NaH2PO4, 50 µM Na2EDTA and 6.25 v/v% ACN. Before adding ACN, the pH 
value of water phase was set to 3.0 with 85 w/w% H3PO4. Test runs showed that mice and rat 
brains can be measured well with this method. 
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Fig. 1 Voltage vs. peak area responses of the analytes and internal standards (a) and the 
effect of the concentration of NaOS (b) or pH (c) in mobile phase to retention times of 
analytes and internal standard. The pH was set to 3.0 and ACN was 5 v/v%. 
 
 
 
ACN acetonitrile; DA dopamine; DHBA 3,4-dihydroxybenzylamine; DOPAC 3,4- 
dihydroxyphenylacetic acid; HVA homovanillic acid; IPR isoproterenol; L-DOPA levodopa; NA 
noradrenaline; NaOS Na-octylsulphate; NM-5HT N-methyl serotonin; 3-MT 3-methoxythyramine; 5-
HIAA 5-hydroxyindoleacetic acid and 5-HT serotonin. 
We only demonstrate the results of the striatum from mice and rats. The results of 
validations are presented in Table 1. In Fig. 2 the native and the spiked chromatograms are 
demonstrated. Native sample is from pooled mice or rat striatum, cortex, hippocampus, 
cerebellum and brainstem regions. 
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Fig. 2 Native and spiked chromatograms of pooled mice (a) and rat (b) brain regions. 
 
 
DA dopamine; DHBA 3,4-dihydroxybenzylamine; DOPAC 3,4- dihydroxyphenylacetic acid; HVA 
homovanillic acid; IPR isoproterenol; L-DOPA levodopa; NA noradrenaline; NM-5HT N-methyl 
serotonin; 3-MT 3-methoxythyramine; 5-HIAA 5-hydroxyindoleacetic acid and 5-HT serotonin. 
Table 1. Summary of validation parameters of HPLC-ECD method for biogenic amines 
in mouse and rat striatum. 
Validation 
parameters 
L-DOPA DOPAC NA 5-HIAA HVA DA 5-HT 3-MT 
Linear 
range 
(ng/ml) 
mouse 
5-150 5-80 5-80 10-100 10-100 5-200 5-100 10-200 
rat 
Correlation 
coefficient 
mouse 1.000 0.999 0.999 0.998 0.994 0.999 0.999 0.998 
rat 0.999 0.999 0.999 0.995 0.993 1.000 0.999 0.997 
LOD 
(ng/ml) 
mouse 1.3 0.5 0.7 5.5 7.4 2.0 3.8 9.8 
rat 3.1 3.6 7.1 7.9 8.6 2.6 3.8 12.8 
LOQ 
(ng/ml) 
mouse 3.9 1.5 2.1 16.5 22.3 6.0 11.6 29.7 
rat 9.3 10.9 21.7 23.9 26.1 7.9 11.4 38.7 
Recovery 
(%) 
mouse 100.7 108.0 110.6 108.9 104.3 109.0 104.4 102.0 
rat 108.0 104.9 106.1 109.0 95.3 106.1 103.5 97.3 
Intraday 
precision 
mouse 3.19 1.81 3.68 3.82 8.23 1.59 5.36 6.70 
rat 1.96 2.57 3.17 2.76 7.28 1.85 3.60 9.74 
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(CV%) 
Interday 
precision 
(bias%) 
mouse 3.24 1.83 3.89 3.85 8.59 1.63 5.42 6.85 
rat 1.98 2.57 3.17 2.75 7.42 1.84 3.62 9.52 
DA dopamine; DOPAC 3,4- dihydroxyphenylacetic acid; HPLC-ECD high-preformance liquid 
chromatography with electrochemical detector; HVA homovanillic acid; L-DOPA levodopa; LOD limit 
of detection; LOQ limit of quantification; NA noradrenaline; 3-MT 3-methoxythyramine; 5-HIAA 5-
hydroxyindoleacetic acid and 5-HT serotonin. 
Discussion 
We successfully extended our latest method with 5 new compounds, of which 2 are internal 
standards. The applied method is suitable for the measurements of brain regions of mice and 
rats. The validation parameters are in line with international guidelines. Based on our results, 
this method will be a valuable tool for multiple experiments, such as, rodent toxin models of 
neurological disorders. 
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